Equities
Health CarePharmaceuticals and Biotechnology
  • Price (SEK)0.348
  • Today's Change0.012 / 3.42%
  • Shares traded339.00k
  • 1 Year change-47.90%
  • Beta1.2126
Data delayed at least 15 minutes, as of Jun 23 2022 17:00 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Abliva AB is a Sweden-based company involved in pharmaceutical industry. The Company focuses on the development of novel treatments for primary mitochondrial diseases.

  • Revenue in SEK (TTM)151.00k
  • Net income in SEK-124.07m
  • Incorporated2000
  • Employees8.00
  • Location
    Abliva ABMedicon Village, Scheeletorget 1LUND 223 81SwedenSWE
  • Phone+46 462756220
  • Fax+46 468888348
  • Websitehttp://abliva.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
SenzaGen AB15.42m-31.35m230.06m16.00--2.09--14.92-1.35-1.350.66584.580.12572.803.85---25.55-25.56-28.66-27.4761.30130.22-203.26-471.453.42--0.0064--93.7998.69-15.38---23.45--
AegirBio AB14.67m-94.31m245.84m1.00--0.5784--16.76-5.27-5.270.852218.940.0674--4.63---43.29---45.04--41.32---642.80--2.24-6.560.005--------------
RLS Global AB862.00k-10.11m260.81m----17.58--302.56-0.1515-0.15150.01290.22070.0364--0.7195---42.64-48.17-52.19-56.91--34.51-1,172.51-1,175.261.40--0.00---68.04-25.6849.96------
ViroGates A/S12.62m-23.51m275.69m14.00--12.94--21.85-5.21-5.212.794.250.37221.304.19---69.36-46.55-80.77-52.0374.62-14.35-186.34-349.763.78-115.200.00--43.0015.745.73------
Kancera AB0.00-48.61m302.62m7.00--2.74-----0.8435-0.84350.001.970.00-------48.53-68.51-54.84-86.40--92.88---5,941.59---99.430.00---100.00---12.80------
Abliva AB151.00k-124.07m316.59m8.00--7.15--2,096.65-0.305-0.3050.00040.04870.002--0.125918,875.00-168.77-67.30-222.48-79.05-----82,165.56-76,095.50---163.760.00---30.0960.91-105.86---43.06--
Nordic Nanovector ASA0.00-457.07m328.32m40.00--0.995-----4.46-4.460.002.770.00----0.00-99.19-69.82-127.27-88.28-------636,940.80---229.600.00-------5.81---29.60--
Alligator Bioscience AB17.68m-152.07m339.70m48.00--1.43--19.21-1.13-1.130.11261.080.0727--7.13384,391.30-62.49-33.26-73.25-36.20-----860.03-672.07----0.0859--197.40-25.981.09---58.36--
Vo2 Cap Holding AB (publ)383.00m-12.63m344.36m--407.692.15894.450.89910.01720.017211.473.262.46--14.98---8.12-31.87-11.69-57.9519.6126.64-3.30-19.29---23.510.1984--46,310.78185.46-246.86------
Herantis Pharma Oyj0.00-136.58m351.84m-----------1.14-1.140.00-0.09770.00-------105.59-65.71-136.72-79.09-----------40.691.19-------39.49------
Arctic Bioscience AS-102.82bn-102.82bn363.40m--------------------------------------------------4.97---88.48------
Bioextrax AB publ358.23k-11.28m365.53m----73.13--1,020.38-0.7651-0.76510.02430.320.054--3.37---169.98---254.58---155.43---3,150.09-----3,073.810.00--1,166.12---89.02------
ISR Immune System Rgultn Hldg AB (publ)0.00-78.62m367.13m----9.53-----1.10-1.100.000.55840.00-------161.95-111.37-208.84-155.17-----------13,101.500.0256-------152.98------
Vivesto AB26.16m-117.97m370.71m19.00--0.5201--14.17-0.2496-0.24960.05631.320.03431.444.941,188,864.00-15.47---18.08---68.59---451.04--6.11-30.480.0116--------------
Scandion Oncology A/S0.00-27.12m374.45m----2.13-----0.7745-0.77450.004.100.00-------14.79---15.68--------------0.0106-------217.81------
SoftOx Solutions AS7.68m-69.07m381.76m----4.36--49.72-7.02-7.020.76448.240.0716--1.03---64.43-44.89-74.64-54.35-----899.50-540.762.17-210.150.0554---19.69139.15-74.85------
Data as of Jun 23 2022. Currency figures normalised to Abliva AB's reporting currency: Swedish Krona SEK

Institutional shareholders

1.60%Per cent of shares held by top holders
HolderShares% Held
SEB Investment Management ABas of 31 May 20222.53m0.63%
Handelsbanken Fonder ABas of 31 May 20221.66m0.41%
Skandia Investment Management ABas of 29 Apr 20221.38m0.34%
Storebrand Asset Management ASas of 31 May 2022637.46k0.16%
Andra AP-fondenas of 31 Dec 2019224.55k0.06%
Catella Fondf�rvaltning ABas of 31 May 202210.69k0.00%
More ▼
Data from 31 Dec 2021 - 31 May 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.